Keystonemab BV is an AI driven, big-data analytics platform leveraging real-time scientific information from millions of scientific, clinical & patent documents using AI to accelerate translation of knowledge from actionable insights of publications which supports in an unprecedented way. Our unique fish-net effect enables the identification of other active-ingredients influencing disease related signaling pathways, gene expressions, drug-targets and biomarkers for multi-drug, synergistic approach. We are specialized in: Identification of synergistic combinations of drugs and APIs Design of multi API new drug formulations for superior efficacy Clinical project rescue (e.g. lack of efficacy) with synergistic combinations Indication expansion of existing and newly developed drug (Drug repositioning) Differential biomarker analysis for identification of new druggable targets Commercial product portfolio analysis for development of market differentiating products Due diligence for in-licensing novel drugs